Table 3.
Associations between CAF phenotype, TILs and clinicopathological data of patients with CRC
| Variables | Cancer-associated fibroblasts (CAFs) phenotype | ||||||
|---|---|---|---|---|---|---|---|
| Expression pattern | |||||||
| Stromal | Tumoral | ||||||
| Biomarker | |||||||
| α-SMA | Fibronectin | FAP-α | Thrombin | Type III Collagen | Fibronectin | Thrombin | |
| TILs | |||||||
| CD3+ cells | r = 0.077 | r = 0.336 | r = 0.204 | r = −0.074 | r = −0.062 | r = 0.331 | r = −0.004 |
| p = 0.504 | p = 0.0026 | p < 0.0001 | p = 0.520 | p = 0.591 | p = 0.003 | p = 0.974 | |
| CD4+ cells | r = −0.031 | r = 0.374 | r = 0.392 | r = 0.167 | r = 0.046 | r = 0.369 | r = 0.115 |
| p = 0.788 | p = 0.001 | p = 0.001 | p = 0.148 | p = 0.690 | p = 0.001 | p = 0.320 | |
| CD8+ cells | r = −0.239 | r = 0.047 | r = 0.204 | r = 0.158 | r = 0.031 | r = 0.124 | r = 0.044 |
| p = 0.035 | r = 0.686 | p = 0.077 | p = 0.171 | p = 0.790 | p = 0.277 | p = 0.701 | |
| CD45+ cells | r = −0.354 | r = 0.321 | r = 0.494 | r = 0.180 | r = 0.072 | r = 0.166 | r = 0.038 |
| p = 0.001 | p = 0.004 | p < 0.0001 | p = 0.117 | p = 0.536 | p = 0.147 | p = 0.746 | |
| Immuno regulators | |||||||
| Stromal | |||||||
| PD-L1 | r = 0.081 | r = 0.357 | r = 0.541 | r = −0.021 | r = 0.096 | r = 0.202 | r = −0.099 |
| p = 0.486 | p = 0.001 | p < 0.0001 | p = 0.854 | p = 0.406 | p = 0.078 | p = 0.390 | |
| CD14 | r = 0.168 | r = 0.160 | r = 0.314 | r = 0.072 | r = 0.065 | r = 0.158 | r = −0.093 |
| r = 0.143 | p = 0.143 | p = 0.006 | p = 0.536 | p = 0.573 | p = 0.171 | p = 0.419 | |
| CD33 | r = 0.141 | r = 0.457 | r = 0.476 | r = −0.151 | r = −0.021 | r = 0.305 | r = 0.083 |
| p = 0.220 | p < 0.0001 | p < 0.0001 | p = 0.190 | p = 0.857 | p = 0.007 | p = 0.475 | |
| IL-2Rα | r = −0.078 | r = 0.059 | r = 0.450 | r = 0.075 | r = −0.035 | r = 0.130 | r = 0.059 |
| p = 0.500 | p = 0.612 | p < 0.0001 | p = 0.519 | p = 0.763 | p = 0.258 | p = 0.611 | |
| Tumoral | |||||||
| PD-L1 | r = 0.112 | r = 0.366 | r = 0.464 | r = −0.077 | r = 0.219 | r = 0.252 | r = 0.148 |
| p = 0.330 | p = 0.01 | p < 0.0001 | p = 0. 506 | r = 0.1485 | p = 0.027 | p = 0.200 | |
| CD14 | r = −0.046 | r = 0.108 | r = 0.039 | r = 0.095 | r = 0.069 | r = 0.186 | r =−0.057 |
| p = 0.692 | p = 0.348 | p = 0.736 | p = 0.413 | p = 0.549 | p = 0.105 | p = 0.624 | |
| CD33 | r = 0.234 | r = 0.365 | r = 0.319 | r = −0.059 | r = 0.033 | r = 0.338 | r = 0.221 |
| p = 0.039 | p = 0.001 | p = 0.005 | p = 0.053 | p = 0.774 | p = 0.002 | p = 0. 053 | |
| IL-2Rα | r = 0.113 | r = −0.076 | r = 0.307 | r = 0. 078 | r = 0.133 | r =−0.003 | r = 0.081 |
| p = 0.509 | p = 0.327 | p = 0.007 | p = 0.499 | p = 0.247 | p = 0.979 | p = 0.059 | |
| Demographic data | |||||||
| Age | r = -0.218 | r = 0.006 | r = 0.145 | r = -0.112 | r = -0.092 | r = -0.041 | r = 0.021 |
| p = 0.055 | p = 0.959 | p = 0.210 | p = 0.332 | p = 0.426 | p = 0.721 | p = 0.853 | |
| Sex (Female/Male) | p = 0.4847 | p = 0.1273 | p = 0.0916 | p = 0.6693 | p = 0.2266 | p = 0.6307 | p = 0.9096 |
| Anatomical site of primary CRC | |||||||
| Left-sided | p = 0.4140 | p = 0.1841 | p = 0.2181 | p = 0.7693 | p = 0.5493 | p = 0.1408 | p = 0.3216 |
| Right-sided | |||||||
| Histopathology | |||||||
| Mucinous | p = 0.8378 | p = 0.5338 | p = 0.5762 | p = 0.6634 | p = 0.4138 | p = 0.1444 | p = 0.0771 |
| Non-mucinous | |||||||
| Macroscopic subtype | |||||||
| Ulcerated | p = 0.5649 | p = 0.6634 | p = 0.1318 | p = 0.6822 | p = 0.0145 | p = 0.9599 | p = 0.1608 |
| Non-ulcerated | |||||||
| Tumor size | p = 0.7887 | p = 0.9465 | p = 0.5271 | p = 0.4142 | p = 0.7297 | p = 0.3786 | p = 0.6877 |
| ≤ 2 cm & > 2 cm | |||||||
| Tumor budding | p = 0.7965 | p = 0.4795 | p = 0.6747 | p = 0.0645 | p = 0.3217 | p = 0.3129 | p = 0.3540 |